| 000 | 01280 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513043856.0 | ||
| 264 | 0 | _c19950125 | |
| 008 | 199501s 0 0 eng d | ||
| 022 | _a1120-009X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJewell, M | |
| 245 | 0 | 0 |
_aCost-containment using an outcome-based best practice model for the management of MRSA. _h[electronic resource] |
| 260 |
_bJournal of chemotherapy (Florence, Italy) _cApr 1994 |
||
| 300 |
_a35-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xeconomics |
| 650 | 0 | 4 | _aColony Count, Microbial |
| 650 | 0 | 4 | _aHospital Bed Capacity, 500 and over |
| 650 | 0 | 4 | _aHospitals, Teaching |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIllinois |
| 650 | 0 | 4 |
_aInfection Control _xeconomics |
| 650 | 0 | 4 |
_aLength of Stay _xstatistics & numerical data |
| 650 | 0 | 4 | _aMethicillin Resistance |
| 650 | 0 | 4 | _aModels, Organizational |
| 650 | 0 | 4 |
_aPatient Readmission _xstatistics & numerical data |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xprevention & control |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tJournal of chemotherapy (Florence, Italy) _gvol. 6 Suppl 2 _gp. 35-9 |
|
| 999 |
_c7798410 _d7798410 |
||